在癌症研究中绘制性别和性少数群体的代表性:一个范围审查协议
Morgan Stirling1, Mikayla Hunter1, Claire Ludwig1
1Department of Community Health Sciences (Stirling, Hunter), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; The Ottawa Hospital (Ludwig), University of Ottawa, Ottawa, Ont.; Women's and Gender Studies Program (Ristock), University of Manitoba, Winnipeg, Man.; Palliative Care Division (Harrison), Bruyère Research Institute, Ottawa, Ont.; Faculty of Health Sciences (Ross-White), Queen's University, Kingston, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Nickel), Rady Faculty of Health Sciences, University of Manitoba; College of Nursing (Schultz), Rady Faculty of Health Sciences, University of Manitoba; Internal Medicine (Banerji), Max Rady College of Medicine, University of Manitoba; CancerCare Manitoba (Banerji), Winnipeg, Man.; School of Nursing (Mahar), Queen's University, Kingston, Ont.
本综述对性别和性少数群体 (GSM) 的癌症结果进行了绘制,确定了影响癌症连续性差异的关键因素. 它强调了GSM人口的研究差距和健康的社会决定因素.
科学领域:
- 在瘤学瘤学.
- 健康 公平 研究 健康 公平 研究
- 公共卫生 公共卫生
背景情况:
- 性别和性少数群体 (GSM) 面临癌症不平等.
- 需要一个强有力的证据基础来解决这些差异.
- 本综述侧重于GSM成年人癌症的结果和影响因素.
研究的目的:
- 绘制有关GSM成年人癌症结局现有文献的地图.
- 确定影响癌症结果的因素.
- 为未来有关GSM群体癌症差异的研究提供信息.
主要方法:
- 根据JBI指南进行混合方法范围审查.
- 在电子数据库中进行系统的文献搜索.
- 用于合成定量和定性数据的元聚合.
主要成果:
- (结果将在审查完成后详细说明)
结论:
- 这一审查将确定研究的差距和局限性.
- 它将突出影响GSM癌症结果的健康社会决定因素.
- 这些发现将指导未来的研究,以减少GSM个体的癌症差异.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
相关概念视频
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Survival Analysis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Prevention
Some...
